1-<2,3-dideoxy-3-C-(hydroxymethyl)-β-D-erythro-pentofuranosyl>thymine | 132235-71-3

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: 1-<2,3-dideoxy-3-C-(hydroxymethyl)-β-D-erythro-pentofuranosyl>thymine
• 英文别名: 1-(4,5-Bis-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione；1-[(2R,4R,5S)-4,5-bis(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
• CAS: 132235-71-3
• 化学式: C₁₁H₁₆N₂O₅
• 分子量: 256.258
• InChiKey: QWMUYDQSNZFVTG-IWSPIJDZSA-N

物化性质

• 密度：
  1.360±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -2.5
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  99.1
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  胸腺嘧啶 在 palladium on activated charcoal 吡啶 、 4-二甲氨基吡啶 、 三甲基氯硅烷 、 ammonium cerium(IV) nitrate 、 偶氮二异丁腈 、 三氟甲磺酸三甲基硅酯 、 氨 、 水 、 氢气 、 三正丁基氢锡 作用下， 以 甲醇 、 1,2-二氯乙烷 、 甲苯 、 乙腈 为溶剂， 反应 23.33h， 生成 1-<2,3-dideoxy-3-C-(hydroxymethyl)-β-D-erythro-pentofuranosyl>thymine
  参考文献：
  名称：

  3'-C支链取代的核苷和核苷酸作为结核分枝杆菌胸苷单磷酸激酶的有效抑制剂。

  摘要：

  结核分枝杆菌（TMPKmt）的胸苷单磷酸激酶（TMPK）代表了一种阻断细菌DNA合成的有吸引力的靶标。为了找到TMPKmt的高亲和力抑制剂，通过在胸苷单磷酸（dTMP）支架的3'-位置引入各种取代基来探索酶在3'-位置的空腔。从一个关键的中间体（23）合成了2'-脱氧核糖（3-6）和核糖系列（7，8）中的各种3'-C支链取代的核苷酸。2'-脱氧类似物被证明是TMPKmt的有效抑制剂：3'-CH（2）NH（2）（4），3'-CH（2）N（3）（3）和3'-CH（2 F（5）个核苷酸在该系列中表现出最高亲和力，K（i）值分别为10.5、12和15 microM。这些结果表明，TMPKmt可耐受在3'-位引入空间上要求的取代基。核糖类似物经历了显着的亲和力降低，这可能是由于Tyr103在2'位置附近的空间位阻。尽管5'-O-磷酸化的化合物对酶具有更高的亲和力，但亲本核苷通常以相同的数量级显示出对

  DOI：

  10.1021/jm021108n

文献信息

• Efficient and Stereoselective Synthesis of 3′-Deoxy 3′ -<i>C</i>-Branched-Chain Substituted Thymidine
  作者：Yogesh S. Sanghvi、Ramesh Bharadwaj、Françoise Debart、Alain De Mesmaeker

  DOI：10.1055/s-1994-25664

  日期：——

  In this report, we provide for the first time a facile, efficient, and stereoselective synthesis of 1-[5-O-(tert-butyldiphenylsilyl)-2, 3-dideoxy-3-C-formyl-β-D-erythro-pentofuranosyl] thymine (12), using an intermolecular radical C-C bond formation reaction. The utility of this compound for antisense application is discussed and, as an extension, 12 was converted into 1-[2,3-dideoxy-3 -C-(hydroxymethyl)-β-D-erythro-pentofuranosyl]thymine (14), a potent antiviral and antitumor agent.

  在本报告中，我们首次利用分子间自由基 C-C 键形成反应，简便、高效、立体选择性地合成了 1-[5-O-(叔丁基二苯基硅烷基)-2,3-二脱氧-3-C-甲酰基-δ²-D-赤式戊呋喃糖基]胸腺嘧啶（12）。讨论了这种化合物在反义应用中的效用，作为延伸，12 被转化为 1-[2,3-二脱氧-3-C-(羟甲基)-δ-D-赤式戊呋喃糖基]胸腺嘧啶（14），这是一种有效的抗病毒和抗肿瘤药物。
• 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections
  申请人：——

  公开号：US20020055483A1

  公开（公告）日：2002-05-09

  The present invention relates to a composition for and a method of treating hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection or a proliferative disorder in a patient using an effective amount of a compound selected from the group consisting of formulas [I]- [IV] below and mixtures of two or more thereof: 1 wherein the substituents are as defined herein. Pharmaceutical compositions comprising these compounds in combination with other HBV, HCV, or HDV agents is also disclosed.

  本发明涉及一种用于治疗患有乙型肝炎病毒（HBV）感染、丙型肝炎病毒（HCV）感染、丁型肝炎病毒（HDV）感染或患有增生性疾病的患者的组合物和方法，所述方法使用从下面的公式I-IV中选择的化合物或两个或两个以上化合物的混合物的有效量：其中，取代基如本文所定义。还公开了包含这些化合物与其他HBV、HCV或HDV药物组合的制药组合物。
• 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
  申请人：Pharmasset, Inc.

  公开号：EP1964569A2

  公开（公告）日：2008-09-03

  The present invention relates to a composition for and a method of treating hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection or a proliferative disorder in a patient using an effective amount of a compound selected from the group consisting of formulas (I)-(IV) below and mixtures of two or more thereof, wherein the substituents are as defined herein. Pharmaceutical compositions comprising these compounds in combination with other HBV, HCV, or HDV agents is also disclosed.

  本发明涉及一种治疗乙型肝炎病毒（HBV）感染、丙型肝炎病毒（HCV）感染、丁型肝炎病毒（HDV）感染或患者增殖性疾病的组合物和方法，使用有效量的选自下式（I）-（IV）组成的组的化合物及其两种或两种以上的混合物，其中取代基如本文所定义。还公开了由这些化合物与其他 HBV、HCV 或 HDV 制剂组合而成的药物组合物。
• Syntheses and biological evaluations of 3'-deoxy-3'-C-branched-chain-substituted nucleosides
  作者：Tai Shun Lin、Ju Liang Zhu、Ginger E. Dutschman、Yung Chi Cheng、William H. Prusoff

  DOI：10.1021/jm00055a006

  日期：1993.2

  Various 3'-deoxy-3'-C-(hydroxymethyl)-, 3'-deoxy-3'-C-(fluoromethyl)-, 3'-deoxy-3'-C-(azidomethyl)-, and 3'-deoxy-3'-C-(aminomethyl)-substituted nucleosides (total 12 compounds) have been synthesized and evaluated against L1210, P388, S-180, and CCRF-CEM cells and HSV-1, HSV-2, and HIV-1 in culture. Only 3'-deoxy-3'-C-(hydroxymethyl)thymidine (36) was found to show significant anticancer activity against L1210, P388, S-180, and CCRF-CEM cells with ED50 values of 50, 5, 10, and 1 muM, respectively. None of these compounds demonstrated significant antiviral activity against HSV-1, HSV-2, or HIV-1. These compounds were also evaluated against thymidine kinases derived from HSV-1 (strain KOS), HSV-2 (strain 333), and mammalian (K562) cells. The thymidine kinase (HSV-1 strain KOS) was inhibited significantly by both 3'-deoxy-3'-C-(hydroxymethyl)- and 3'-deoxy-3'-C-(fluoromethyl)thymidine.
• Synthesis of 2',3'-dideoxy-3'-C-hydroxymethyl nucleosides as potential inhibitors of HIV
  作者：Lars Svansson、Ingemar Kvarnstroem、Bjoern Classon、Bertil Samuelsson

  DOI：10.1021/jo00009a012

  日期：1991.4

  A novel synthesis of 2',3'-dideoxy-3'-C-hydroxymethyl nucleosides is described. (2S,3R)-3-[[(4-Bromobenzyl)oxy]methyl]oxirane-2-methanol (1) was regioselectively alkylated using allylmagnesium bromide. The allyl double bond was oxidatively cleaved, and the product was treated with acidic methanol to give the requisite methyl furanoside derivative 5, which was subsequently condensed with purine and pyrimidine bases. Deblocking and separation of the anomers by chromatography afforded the alpha- and beta-nucleoside analogues.